Evidence map›Paper›PMID 34584471›Full record

ArticleRisk management and healthcare policy2021

Efficacy of Additional Intervention to the Specific Health Guidance in Japan: The Takahata GENKI Project.

Nao Enomoto, Sho Nakamura, Satoru Kanda, Hiroko Endo, Emiko Yamada, Sachiyo Kobayashi, Miki Kido, Rina Inoue, Junko Shimakura, Hiroto Narimatsu

Open access · goldAbstract read
In one paragraph

Article in Risk management and healthcare policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nao EnomotoSection of Health and Longevity Service, Takahata Town Office, Takahata, Yamagata, Japan.
Sho NakamuraGraduate School of Health of Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Satoru KandaCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan.
Hiroko EndoSection of Health and Longevity Service, Takahata Town Office, Takahata, Yamagata, Japan.
Emiko YamadaSection of Health and Longevity Service, Takahata Town Office, Takahata, Yamagata, Japan.
Sachiyo KobayashiSection of Health and Longevity Service, Takahata Town Office, Takahata, Yamagata, Japan.
Miki KidoSection of Health and Longevity Service, Takahata Town Office, Takahata, Yamagata, Japan.
Rina InoueCIKOP, Specified Nonprofit Corporation, Yamagata, Japan.
Junko ShimakuraSection of Welfare and Child Service, Takahata Town Office, Takahata, Yamagata, Japan.
Hiroto NarimatsuGraduate School of Health of Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Kanagawa Cancer CenterKanagawa University of Human Services · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA tailored approach to individual risk factors for developing lifestyle-related diseases would help induce behavioral changes toward intervention acceptability. The addition of preventive healthcare programs to nationwide specific health guidance in Japan is adapted in a given region. PATIENTS AND

methodsWe conducted a prospective parallel-group comparison study on 195 eligible residents from Takahata, Japan, with a high risk of lifestyle-related diseases from 2014 to 2017 to examine whether such an intervention could improve the body mass index (BMI) and estimated glomerular filtration rate (eGFR).

resultsOf the 195 enrolled residents, 117 were assigned to the control group and 78 to the intervention group. They were ≤65 years old and had a BMI ≥25 kg/m

conclusionThe additional interventions might have contributed to a reduction in metabolic syndrome.

trial registrationThis study was registered in the UMIN-Clinical Trials Registry (ID:000013581). More information: https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015868. The registration date was 31/03/2014.

Indexed as

body mass indexestimated glomerular filtration ratemedical costpersonalized preventive medicine

Identifiers

PMID34584471
PMCPMC8464379
OpenAlexW3200796207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.